Aptevo Therapeutics Inc. (NASDAQ:APVO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anatolio B Cruz III Other companies: Graf Acquisition Corp IV (Director · May 20, 2021 – May 20, 2021 · Past); Scripps Networks Interactive Inc (CLO & Corporate Secretary · Jul 1, 2008 – Aug 14, 2012 · Past); E.W. Scripps Company (The) (EVP & General Counsel · Feb 15, 2006 – Jul 1, 2008 · Past) | Director · Jul 15, 2016 – Jul 15, 2016 · Past |
| Marvin L. White Other companies: Emergent BioSolutions Inc. (Independent Director · Since at least Jun 1, 2010); CoLucid Pharmaceuticals Inc (Director · Jul 9, 2015 – Mar 1, 2017 · Past); Washington Prime Group Inc (Director · May 8, 2014 – Aug 4, 2014 · Past) | Executive Chair · Since at least Jul 29, 2016 |
| Fuad El-Hibri Other companies: Emergent BioSolutions Inc. (Director · Nov 14, 2006 – Dec 3, 2021 · Past) | Director · Aug 1, 2016 – Dec 3, 2021 · Past |
| John E. Niederhuber Other companies: Emergent BioSolutions Inc. (Director · Aug 23, 2010 – May 18, 2016 · Past) | Lead Independent Director · Since at least Aug 1, 2016 |
| Robert Kramer Other companies: Emergent BioSolutions Inc. (President and CEO, Director · May 31, 2013 – Jun 9, 2023 · Past) | President, Director · Jul 15, 2016 – Jul 15, 2016 · Past |
| Zsolt Harsanyi Other companies: Emergent BioSolutions Inc. (Independent Director, Chairman of the Board · Since at least Nov 14, 2006) | Director · Since at least Jul 15, 2016 |
| Barbara Lopez Kunz | Director · Since at least Aug 1, 2016 |
| Daniel J. Abdun-Nabi | Director · Since at least Jul 17, 2025 |
| Daphne Taylor | SVP, CFO · Since at least Mar 3, 2023 |
| Dirk Huebner | Senior Vice President and Chief Medical Officer · Since at least Jul 1, 2025 |
| Eric M Burt | Director · Jul 15, 2016 – Jul 15, 2016 · Past |
| Grady Grant III | Director · Since at least Aug 1, 2016 |
| Jeff Lamothe | President and Chief Executive Officer · Since at least Aug 10, 2026 |
| Jeffrey G Lamothe | President and CEO, Director · Since at least Jul 29, 2016 |
| Mary J. Janatpour | Senior Vice President and Chief Scientific Officer · Since at least May 20, 2026 |
| Michael Adelman | SVP, Commercial Operations · Nov 1, 2019 – Feb 18, 2020 · Past |
| Michael Darling | Director · Jul 15, 2016 – Jul 15, 2016 · Past |
| Miriam Weber Miller | Vice President, Investor Relations and Corporate Communications · Since at least Oct 26, 2026 |
| Scott C Stromatt | Chief Medical Officer and SVP · Jul 29, 2016 – Feb 28, 2019 · Past |
| SoYoung Kwon | Senior Vice President and General Counsel, Business Development and Corporate Affairs · Since at least May 24, 2021 |